Pathogenesis, diagnosis and treatment of immune checkpoint inhibitor related bullous pemphigoid
As a new type of anti-tumor therapy, immune checkpoint inhibitor (ICI) can effectively improve the survival rate of tumor patients, but also bring a series of adverse reactions. Among these, immune-related cutaneous adverse events are prevalent. There is a relatively low incidence of bullous pemphig...
Shranjeno v:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Shanghai Chinese Clinical Medicine Press Co., Ltd.
2025-04-01
|
| Serija: | Zhongguo Linchuang Yixue |
| Teme: | |
| Online dostop: | https://www.c-jcm.com/article/doi/10.12025/j.issn.1008-6358.2025.20241038 |
| Oznake: |
Brez oznak, prvi označite!
|